2025-02-23T00:10:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: Query fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-139012%22&qt=morelikethis&rows=5
2025-02-23T00:10:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: => GET http://localhost:8983/solr/biblio/select?fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-139012%22&qt=morelikethis&rows=5
2025-02-23T00:10:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: <= 200 OK
2025-02-23T00:10:43-05:00 DEBUG: Deserialized SOLR response
Comparative study of anticancer efficacy of aсonitinecontaining agent BC1 against ascite and solid forms of Ehrlich’s carcinoma

Comparative study of anticancer efficacy of aсonitinecontaining agent BC1 against ascite and solid forms of Ehrlich’s carcinoma

Aim: To study anticancer activity of аconitine-containing agent BC1 in vivo. Methods: BC1 water solution was administered per os to mice bearing ascite or solid form of Ehrlich’s carcinoma. Anticancer effect of BC1 administered per os was evaluated by the indexes of tumor growth inhibition and avera...

Full description

Saved in:
Bibliographic Details
Main Authors: Dasyukevich, O.I., Solyanik, G.I.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2007
Series:Experimental Oncology
Subjects:
Short communications
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/139012
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: To study anticancer activity of аconitine-containing agent BC1 in vivo. Methods: BC1 water solution was administered per os to mice bearing ascite or solid form of Ehrlich’s carcinoma. Anticancer effect of BC1 administered per os was evaluated by the indexes of tumor growth inhibition and average life span of experimental animals. Results: BC1 didn’t show anticancer activity in the case of ascite form of Ehrlich’s carcinoma. At the same time treatment with BC1 resulted in 77.3% growth inhibition of solid form of Ehrlich’s carcinoma (p < 0.05). Conclusion: BC1 is active in vivo against tumor with angiogenesis-dependent growth.

Similar Items